Gene therapy scores big wins against blood cancers
Gene therapy transformed patients' blood cells into attack cells for leukemia and other blood cancers. Across six groups, more than 120 patients show complete remissions and strong responses, with some children like Emily Whitehead remaining cancer free nearly two years after treatment. Researchers caution about relapses and note costs, side effects, and ongoing trials toward potential approval.
MENTIONED IN THIS ARTICLE
Janis Abkowitz
University of Washington
Seattle
American Society of Hematology
Emily Whitehead
Philipsburg
Hematology
New Orleans
United States
Europe
David Porter
University of Pennsylvania
Penn
Switzerland
Novartis AG
Philadelphia
Herri Hoppenot
Novartis Oncology
Lee Greenberger
Leukemia and Lymphoma __ Society
Porter
Stephan Grupp
Children’s Hospital of
National Cancer Institute
James Kochenderfer
Kechenderfer
The
Cancer Institute
Los Angeles
Kite Pharma Inc
Memorial Sloan-Kettering Cancer Center
University of Texas MD Anderson Cancer Center
Baylor University
Tom Whitehead
Emily
Doug Olson
Olson
Also Mentioned on This Page
Richlands Area
Bluefield Daily Telegraph
Marketplace
S&p Capital IQ Financial Communications
S&p Capital 1Q Financial Communications
S&p Capital
Q Financial Communications
LPL Financial
FINRA
SIPC
Ipabluefield.com
Cumberland Road
Bluefield